Collaboration and Other Agreements - Celera Corporation (Details Narrative) (Celera Corporation Agreement, USD $) In Thousands, unless otherwise specified	12 Months Ended
Jun. 30, 2012	Apr. 30, 2006
Celera Corporation Agreement
Maximum future milestone payments		$ 97,000
Description of future milestone payment	Approximately two-thirds of the milestone payments relate to our HDAC Inhibitor program and approximately one-third relates to our Factor VIIa program
Potential future milestone payments to be paid to Celera after regulatory approval (as percentage)	90.00%

A description of each milestone and related contingent consideration as well as a description of whether or not each milestone(s) is considered substantive.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 28

-Section 50

-Paragraph 2

-Subparagraph (b,c)

-URI http://asc.fasb.org/extlink&oid=19771982&loc=SL6892177-166501

Name:	us-gaap_RevenueRecognitionMilestoneMethodMilestone
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration